For more information on Infinity, please refer to Infinity's website at www.infi.com. Cautionary Note Regarding Forward ... developments in Infinity's product portfolio will result in stock price appreciation. Management's expectations and, …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at https://www.zacks.com/ap/INFI Keywords: Infinity Pharmaceuticals, …
Yahoo!9mon
On October 16, 2017, the Company announced the closing of its initial public offering of 3.57 million shares of common stock at a public offering price of $7.00 each. The Company's common stock began trading on The NASDAQ Global …
Infinis Energy has started trading on the London Stock Exchange's main market under the ticker INFI. The company says its entire ordinary share capital of 300,000,000 shares has been admitted to the premium listing segment of the Official …
--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the expansion of its pipeline ...
Softech Infinium Solutions Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 09, 2015 to September 23, 2015 (both days inclusive) for the purpose of Annual …
With this restructuring, Infinity regains worldwide rights for its phosphoinositide-3-kinase ... development and commercialization rights for its PI3K, FAAH and early discovery programs, and Mundipharma will no longer provide …
Infinity-Bristol-Myers Clinical Trial Collaboration Expanded: Infinity Pharmaceuticals's INFI existing clinical collaboration with ... AbbVie is a Zacks Rank #3 (Hold) stock - you can see the complete list of today’s Zacks #1 Rank (Strong Buy) …
Infinity Pharmaceuticals, Inc. INFI reported a loss of 14 cents per share in third ... Infinity has a Zacks Rank #3 (Hold). A better-ranked stock in the health care sector is Exelixis, Inc. EXEL, carrying a Zacks Rank #2 (Buy). You can see the …